JUN and neoplasm: Accordingly, immunostaining in 41 tumor and unaffected adjacent tissues showed reduced levels of JUN; downregulation at the transcript level was also observed for JUN, FOS (Fos proto-oncogene, AP-1 transcription factor subunit), and CCND2.